1297655-08-3
1297655-08-3
Chemical Structure
Decanoyl-L-carnitine-d3
Synonym(s): (-)-Decanoylcarnitine-d3
- CAS No.: 1297655-08-3
- Formula:C17H30D3NO4
- Molecular Weight:318.47
IUPAC Name: (R)-3-((tetradecanoyl-14,14,14-d3)oxy)-4-(trimethylammonio)butanoate hydrochloride
InChIKey: LZOSYCMHQXPBFU-DDOHFVCQSA-N
SMILES: [2H]C([2H])([2H])CCCCCCCCC(O[C@H](CC([O-])=O)C[N+](C)(C)C)=O
Biological Activity: Decanoyl-L-carnitine ((-)-Decanoylcarnitine)-d3 is deuterium labeled Decanoyl-L-carnitine (HY-135035). Decanoyl-L-carnitine is an endogenous metabolite. Decanoyl-L-carnitine can be used as a serum metabolic biomarkers as indicators in the progression of intravenous leiomyomatosis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Decanoyl-L-carnitine-d3 | Decanoyl-L-carnitine ((-)-Decanoylcarnitine)-d3 is deuterium labeled Decanoyl-L-carnitine (HY-135035). Decanoyl-L-carnitine is an endogenous metabolite. Decanoyl-L-carnitine can be used as a serum metabolic biomarkers as indicators in the progression of intravenous leiomyomatosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Decanoyl-L-carnitine (Standard) | ≥98% | Decanoyl-L-carnitine ((-)-Decanoylcarnitine) (Standard) is the analytical standard of Decanoyl-L-carnitine (HY-135035). This product is intended for research and analytical applications. Decanoyl-L-carnitine is an endogenous metabolite. Decanoyl-L-carnitine can be used as a serum metabolic biomarkers as indicators in the progression of intravenous leiomyomatosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Decanoyl-L-carnitine-d19 | Decanoyl-L-carnitine-d19 ((-)-Decanoylcarnitine-d19> is the deuterium labeled Decanoyl-L-carnitine (HY-135035). Decanoyl-L-carnitine ((-)-Decanoylcarnitine) is an endogenous metabolite. Decanoyl-L-carnitine can be used as a serum metabolic biomarkers as indicators in the progression of intravenous leiomyomatosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Decanoyl-L-carnitine | 99.85% | Decanoyl-L-carnitine ((-)-Decanoylcarnitine) is an endogenous metabolite. Decanoyl-L-carnitine can be used as a serum metabolic biomarkers as indicators in the progression of intravenous leiomyomatosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
